Listeriosis is caused by the food-borne pathogen Listeria monocytogenes, which can be found in seafood and processing plants. To evaluate the risk to human health associated with seafood production in New Zealand, multi-virulence-locus sequence typing (MVLST) was used to define the sequence types (STs) of 31 L. monocytogenes isolates collected from seafood-processing plants, 15 from processed foods, and 6 from human listeriosis cases. The STs of these isolates were then compared with those from a collection of seafood isolates and epidemic strains from overseas. A total of 17 STs from New Zealand clustered into two lineages: seafood-related isolates in lineages I and II and all human isolates in lineage II. None of the New Zealand STs matched previously described STs from other countries. Isolates (belonging to ST01-N and ST03-N) from mussels and their processing environments, however, were identical to those of sporadic listeriosis cases in New Zealand. ST03-N isolates (16 from mussel-processing environments, 2 from humans, and 1 from a mussel) contained an inlA premature stop codon (PMSC) mutation. Therefore, the levels of invasiveness of 22 isolates from ST03-N and the three other common STs were compared using human intestinal epithelial Caco-2 cell lines. STs carrying inlA PMSCs, including ST03-N isolates associated with clinical cases, had a low invasion phenotype. The close relatedness of some clinical and environmental strains, as revealed by identical MVLST profiles, suggests that local and persistent environmental strains in seafood-processing environments pose a potential health risk. Furthermore, a PMSC in inlA does not appear to give L. monocytogenes a noninvasive profile.
L
isteria monocytogenes is an important food-borne pathogen that causes listeriosis (1) . Listeriosis usually manifests itself as a gastrointestinal illness, but in some cases, more serious symptoms are observed, such as meningitis or septicemia (1) . High-risk populations include immunocompromised individuals, infants, and the elderly. Infection in these populations results in a high mortality rate (1) . In 2011, the reported incidence of listeriosis in New Zealand was 0.6/ 100,000 people (the highest rate in an English-speaking country), with 21 food-related cases leading to one death (2) . The New Zealand Food Safety Authority (now within the Ministry for Primary Industries), has reviewed its risk management strategy across all food sectors with the aim of ensuring that the rate of listeriosis cases in the New Zealand population does not increase (3, 4) .
Molecular subtyping has shown that isolates cluster into at least four evolutionary lineages (I, II, III, and IV) with different but overlapping ecological niches (5-7). The division into four lineages is consistent with serotype classification, which has separated L. monocytogenes into 13 serotypes (8) . L. monocytogenes isolates belonging to lineage I serotypes 1/2b and 4b are the predominant causes of listeriosis in humans. Molecular epidemiology studies have identified three highly clonal lineage I serotype 4b strains, termed epidemic clones I, Ia, and II, which have been associated recurrently with outbreaks of the disease globally (7) . Lineage II isolates, which are predominantly serotype 1/2a, have also been implicated in a number of recent outbreaks of listeriosis (9) (10) (11) (12) . Members of this highly diverse group, however, are also commonly isolated from the environment, including from foodprocessing plants and food samples. Lineage III and IV isolates, mostly belonging to serotypes 4a and 4c, are rare and are predominantly isolated from animal sources (8) .
Various subtyping strategies discriminate closely related L. monocytogenes strains and are used to identify the sources of listeriosis outbreaks. Among them, pulsed-field gel electrophoresis (PFGE) is the most common and is used routinely in diagnostic laboratories throughout the world (13) . Analysis of PFGE profiles, however, can be subjective, so DNA-sequencing-based techniques, such as multilocus sequence typing (MLST), have been developed to overcome the ambiguities of the fragment-based techniques and to enable easy exchange and comparison of data via publically available databases (14, 15) . More recently, multi-virulence-locus sequence typing (MVLST) has been used as an alternative to MLST. Unlike MLST, which utilizes slowly diversifying housekeeping genes and can have low discriminatory power, MVLST targets more rapidly evolving virulence genes (16) . The higher level of sequence polymorphisms associated with MVLST has enabled local epidemiological studies, often differentiating outbreak and epidemic strains from other isolates (17, 18) . Cantinelli et al. (19) , however, recently compared 125 L. monocytogenes strains and found that MVLST and MLST provided similar sequence types (STs), phylogenetic clustering, and discriminatory power. Mutations in virulence genes are associated with a reduced invasion phenotype in L. monocytogenes. Perhaps the best-studied polymorphisms leading to virulence attenuation are those in the gene encoding the surface protein internalin A (InlA). InlA plays a critical role in the invasion of L. monocytogenes into human intestinal epithelial cells (20) . Screening of L. monocytogenes isolated from human clinical cases, ready-to-eat (RTE) foods, and foodprocessing environments has revealed mutations in inlA leading to premature stop codons (PMSCs) (21) (22) (23) , particularly among lineage II isolates of serotypes 1/2a and 1/2c (6) . To date, at least 18 naturally occurring single nucleotide polymorphisms leading to a PMSC in inlA have been identified (23) . Strains containing these PMSCs produce a truncated InlA protein and are generally less invasive than those without a PMSC (24) .
Little is understood about the L. monocytogenes strains that exist in food-processing systems or about the sources of listeriosis cases in New Zealand. As a consequence, the risks that these strains pose to human health are unknown. Recently, a study of the prevalence and persistence of L. monocytogenes in seafood factories showed that in-house isolates are frequently found in the processing environment, but rarely in final products (25) .
The aims of this study were (i) to investigate, using MVLST, the prevalence of L. monocytogenes STs in the seafood-processing environment and associated with food and human infection in New Zealand; (ii) to compare New Zealand L. monocytogenes STs with strains from different sources and geographic locations internationally, including key epidemic strains; (iii) to screen STs for the presence of previously described inlA PMSC mutations (types 1 to 18); and (iv) to establish the potential virulence of prevalent environmental STs in New Zealand based on their ability to invade human epithelial Caco-2 cells.
MATERIALS AND METHODS

Bacterial isolates.
A total of 52 L. monocytogenes isolates obtained from New Zealand seafood-processing environments (non-food contact), food, or human listeriosis cases were used in this study. Strains with the same PFGE profile (25) were included when they were obtained on different dates or from different locations within a seafood-processing plant. Clinical and nonseafood food isolates were supplied by Environmental Science & Research (ESR), Christchurch, New Zealand. All bacterial isolates were stored at Ϫ85°C on beads in cryopreservative medium containing 1% NaCl (Merck, Damstadt, Germany), 0.8% nutrient broth (Difco, BD, Sparks, MD), and 1.5% glycerol (Merck). Isolates were recovered by inoculation in Trypticase soya broth (Difco) enriched with 0.6% (wt/vol) yeast extract (Difco) (TSB-YE). The New Zealand isolates used in this study are described in Table 1 .
MVLST. Bacterial genomic DNA was extracted using a DNeasy tissue kit (Qiagen). For each bacterial strain, the intragenic regions of three virulence genes (inlB, inlC, and prfA) and three virulence-associated genes (lisR, clpP, and dal) were amplified using primers designed in previous studies (16, 17) . PCRs were performed in a total volume of 25 l containing 1.0 l template DNA (1 to 10 ng/l). The final concentrations of individual PCR components were as follows: 1ϫ buffer, 0.16 mM deoxyribonucleotide triphosphates, 1.5 mM MgCl 2 , 0.8 M appropriate primers, and 0.05 unit Taq DNA polymerase (Invitrogen). Reaction conditions were as follows: initial denaturation at 94°C for 4 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 1 min and a final extension step of 72°C for 5 min. PCR fragments were purified with a QIAquick PCR purification kit (Qiagen) and were subsequently sequenced in both directions using an Automatic Sequencer 3730x (Macrogen Inc.). The primers used for amplification of each PCR product were also used in sequencing reactions. DNA sequences were then assembled and trimmed with Sequencher 4.5 (Gene Codes) and deposited in GenBank.
DNA sequence analysis. Multiple alignments of DNA sequences for inlB, inlC, prfA, lisR, clpP, and dal were performed using ClustalX v 1.81 (26) . For each gene, DNA sequences with at least 1 nucleotide difference were assigned as a unique allele. For each strain, the combination of six alleles defined its allelic profile, and a unique profile was designated an ST using a numeric system. A neighbor-joining (NJ) tree was then constructed for the STs of L. monocytogenes using the heuristic search algorithm in PAUP v 4.0 (27) . Confidence measures for NJ branch points were generated by performing 1,000 bootstrap replicates. DNA sequences from the International Life Sciences Institute North America (ILSI NA) collection (28) were retrieved from GenBank for comparison ( (29) were also used in comparisons ( Table 2) . DNA sequences for lineage III isolates were used to root the NJ tree, as they are more distantly related to lineages I and II (30) .
Screening for inlA PMSCs. Partial inlA DNA sequences spanning regions associated with previously defined PMSCs (mutation types 1 to 18) (23, 24) were obtained for the New Zealand clinical and environmental isolates. PCRs were performed as previously described using primers inlA-F and inlA-R (24) . Each PCR amplicon was sequenced in both directions, as previously described, and the presence of PMSCs was established by the identification of in-frame stop codons within the resulting inlA gene sequence.
Cell culture invasion assay. Invasion assays were performed on Caco-2 cells using a selection of strains from the most prevalent New Zealand STs, as previously described by Gaillard et al. (31) . Assays were conducted using Caco-2 cells, as efficient invasion of these human intestinal epithelial cells requires InlA and is indicative of virulence (32) . Caco-2 cells were grown using minimal essential medium (MEM) (Life Technologies, Carlsbad, CA) supplemented with 1% sodium pyruvate (Life Technologies), 1% nonessential amino acids (Life Technologies), and 10% fetal bovine serum (Life Technologies). For each experiment, 1.2 ϫ 10 5 Caco-2 cells were seeded into each well of a 24-well plate (Corning, Lowell, MA) in MEM and incubated for 24 h at 37°C under 5% CO 2 to form a monolayer. At the same time, each L. monocytogenes isolate was grown in brain heart infusion (BHI) broth (Difco) overnight at 37°C with shaking at 200 rpm. The following day, a 10-fold dilution of each overnight culture was prepared, and the bacteria were grown under the same incubation conditions until logarithmic phase (optical density at 600 nm [OD 600 ] ϭ 1.0). An aliquot (100 l) of each bacterial suspension (ca. 1 ϫ 10 7 ) was then added to a single well containing a Caco-2 monolayer to obtain a final multiplicity of infection (MOI) of 100:1 (bacteria/cell). The resulting 24-well plate was incubated for 30 min at 37°C, and each well was washed twice with phosphate-buffered saline (PBS) (Life Technologies). Fresh MEM containing 100 g/ml of gentamicin (Life Technologies) was then added to each well, and the plate was incubated for 1 h at 37°C prior to washing twice with PBS. The cells were lysed by the addition of 1% Triton X-100 (Sigma-Aldrich, St. Louis, MO) and vigorous pipetting. For each isolate, the numbers of viable bacteria in the initial inoculum and of those released from lysed Caco-2 cells after incubation were compared by plating a dilution series of each on TSB-YE agar using the drop plate technique (5 drops of 10 l each). CFU were counted after 24 h at 37°C. The invasion efficiency was calculated as the percentage of the initial inoculum recovered from a Caco-2 monolayer. The relative invasion efficiency was subsequently calculated by comparison of the invasion efficiency for each strain to that of the control strain, Scott A (defined as 100%). L. monocytogenes Scott A has been widely used as a reference strain for testing the efficacy of preservation techniques (33) and in virulence studies (34) , and its genome was recently published (35) . Three independent assays were performed, and each strain was tested in duplicate in each assay.
Statistical analysis. Analysis of variance was used to compare the capacities of L. monocytogenes strains to invade Caco-2 cells. The invasiveness data were square-root transformed to stabilize variability before analysis. Tukey's test was used to compare the means to identify which were significantly different (P Ͻ 0.05).
Nucleotide sequence accession numbers. The DNA sequences assembled in this study were deposited in GenBank under accession number KC290711 and PMSCs within the inlA gene sequence under accession numbers KC594235 to KC594285.
RESULTS
MVLST confirms the similarity of environmental and human isolates in New Zealand and distinguishes them from international strains. A total of 301 single nucleotide polymorphisms spanning three virulence genes and three virulence-associated genes were identified among environmental-, food-, and humanrelated L. monocytogenes isolates. The numbers of unique alleles from the selected genes ranged from 10 for lisR to 22 for dal, and the percentages of polymorphic sites varied between 8.32% for prfA and 18.46% for dal ( Table 3) .
The 301 nucleotide polymorphisms differentiated the 52 New Zealand L. monocytogenes isolates into 17 STs (Table 1) . Just seven of the STs represented all the isolates collected from the seafoodprocessing environment (n ϭ 31) in New Zealand. Of these STs, ST01-N and ST03-N comprised the majority (80.6%) of the isolates, indicating that they are widespread and recurrent in seafood-processing plants in New Zealand. The human isolates were seemingly more diverse, with six strains represented by four STs. a Data obtained in a previous study (6) . b STs of MVLST groups were assigned based on concatenated DNA sequences derived from inlB, inlC, dal, lisR, clpP, and prfA. Different numbers represent different STs. c N, absence of inlA mutation; Y, presence of inlA mutation type 3; amino acid, amino acid position of inlA mutation type 3. d Cultures were isolated in our previous study (25) . e Cultures were supplied by ESR.
Three of the human isolates, however, had STs identical to those of prevalent environmental strains (one ST01-N and two ST03-N) ( Table 1) . Thirteen STs represented the 15 food-related isolates, some overlapping the STs for isolates collected from the seafoodprocessing environment and clinical samples. All STs for New Zealand isolates were distinct from those associated with epidemic strains or with food production overseas, including those from Japanese RTE seafood products. The STs for all overseas strains are described in Table 2 . Cluster analysis differentiated the 17 STs of L. monocytogenes from New Zealand and overseas into three main groups: cluster A, cluster B, and cluster C (Fig. 1) . Cluster A corresponds to lineage I, cluster B to lineage II, and cluster C to lineage III. STs collected from New Zealand seafood-processing plants clustered within lineages I and II and represented serotypes 1/2a or 3a. All STs from seafood products also clustered within lineages I and II and, with the exception of ST02-N, were of the same serotype. Furthermore, all but one ST from other foods in New Zealand clustered closely with the STs of isolates from seafood and seafood-processing plants. All four STs associated with human isolates from New Zealand belonged to lineage II and clustered with those from processing environments and food products. Although isolates from Japanese RTE seafood products had different STs, with the exception of ST25-J and ST24-J, all clustered closely (with strong bootstrap support) with the New Zealand STs within lineages I and II. They did, however, represent serotypes 1/2b, 3b, and 4b, as well as 1/2a and 3a (29) . In contrast, none of the human epidemic STs from overseas, which belong to lineage I and serotype 4b, clustered strongly with STs from New Zealand seafood or seafood-processing environments. Furthermore, only one ST (ST01-I) associated with a sporadic human infection overseas clustered with STs from New Zealand, but interestingly, this ST was most similar to two of the four STs for clinical isolates in New Zealand.
Presence of PMSC mutation type 3 in prevalent STs and human isolates. Partial DNA sequencing of the inlA gene from all isolates of L. monocytogenes from New Zealand revealed only one I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I   ST15-I  ST16-I  ST26-I  ST28-I  ST27-I   ,  4a  4a  4b  4c  4c   III  III  III  III  III II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II  II nonsense mutation in inlA, at amino acid position 700. This mutation corresponded to PMSC mutation type 3. In total, 21 of the 52 (40.4%) New Zealand isolates carried a PMSC type 3 mutation ( Table 1 ). The majority (90%) belonged to ST01-N. Most of the isolates encoding a truncated form of InlA were from environmental samples (n ϭ 16; 76.2% of the total truncated strains), although some were obtained from human samples (n ϭ 2; 9.5%) or from food, including seafood (n ϭ 3; 14.3%). Invasiveness of L. monocytogenes STs prevalent in New Zealand. All isolates belonging to ST03-N showed an invasion capacity of less than 10% in Caco-2 human intestinal epithelial cells compared with the Scott A strain (P Ͻ 0.05), independent of their sources of isolation (Table 1 and Fig. 2) . In contrast, ST01-N isolates, which did not contain known virulence-attenuating mutations in the partially sequenced inlA gene, varied in virulence: some strains presented less than 10% invasiveness (similar to PMSC inlA strains; P Ͻ 0.05), whereas others reached approximately 50% of the Scott A strain value (P Ͻ 0.05) (Fig. 2) . There appeared to be no relationship between invasiveness and the source of the isolates (environment, food, and/or human) (P Ͼ 0.05). Isolates 16A01 and 18F03 were obtained from smoked mussels and a human clinical sample, respectively, and were linked to the only New Zealand seafood-related listeriosis outbreak that occurred in 1992 (36) . Although both belong to ST01-N, these strains showed different invasion capacities (P Ͻ 0.05), with the human isolate expressing 10 times greater invasion than the seafood isolate.
DISCUSSION
In this study, MVLST identified common STs for seafood-related and clinical L. monocytogenes isolates, which were unique to New Zealand. MVLST also showed that seafood-related isolates were homogeneous and recurrent within the factories, while human isolates were relatively diverse. A large number of the seafoodrelated isolates and several clinical isolates carried a type 3 inlA PMSC with reduced invasiveness, supporting the hypothesis that expression of InlA may result in a fitness cost to the bacterium. Furthermore, L. monocytogenes may cause infection in an inlAindependent manner.
MVLST is a method that uses highly discriminatory loci that have been shown to differentiate epidemic strains in a manner comparable with PFGE (16, 17) . Of the six virulence-related genes established for typing L. monocytogenes, dal, lisR, and inlB are the most discriminatory. Between 12 and 19% of the nucleotides in these genes are polymorphic (17) . In particular, the inclusion of inlB contributes to the differentiation of strains of serotypes 1/2a and 4b, as well as epidemiologically unrelated strains within serotypes. Consistent with these observations, the most polymorphic gene in our study was dal (18% of the nucleotides in the gene were polymorphic), followed by lisR (12%) and inlB (11%).
MVLST identified 17 STs from a selection of L. monocytogenes isolates collected from seafood-processing environments, seafood, other foods, and New Zealand clinical cases. The differentiation of the 52 isolates into 17 STs was consistent with their discrimination using PFGE. However, PFGE was more discriminatory than MVLST, as PFGE identified 21 pulsotypes. Regardless, the more subjective nature of PFGE and the ease in comparing DNA sequence data from multiple studies indicates that MVLST may be more useful for defining L. monocytogenes strains, their prevalences, and their associations with clinical cases of listeriosis. For example, MVLST distinguished one isolate linked to listeriosis (ST15-N) from food and environmental isolates (ST13-N). This was not possible using PFGE.
Several STs of L. monocytogenes are widespread in seafoodprocessing plants in New Zealand, yet none of them match those of the international isolates, which include isolates from Japanese seafood products (29) and a collection of epidemic strains (28 cytogenes that were widely distributed in one country are often distinct, with few strains from different geographical regions in the world having the same genotype. The unique genotypes of isolates in different countries indicate that spread of L. monocytogenes globally is limited and that the highest risk associated with the microorganism is most likely from local strains.
Even though genotypes of L. monocytogenes are largely restricted to distinct geographical localities, a previous study conducted with 300 L. monocytogenes strains from 42 different countries on five continents using MLST showed that a subset of clones of clinical isolates appear to be distributed worldwide (37) . A clear genotypic partition can be observed between these clinical isolates and those from food or the environment. In our MVLST study, environmental, food, and human isolates had the same or similar STs, consistent with their closely related or identical pulsotypes (25) . Identical genotypes of isolates from these sources confirm that local, environmentally persistent strains are epidemiologically important in listeriosis in New Zealand. In particular, the identification of isolates from the seafood-processing environments with the same STs as those isolated from sporadic cases of listeriosis demonstrates the potential health risk associated with seafood. Furthermore, the close relationship of ST04-N (from the seafood-processing environment) and clinical STs from New Zealand (ST01-N and ST17-N) with a sporadic human isolate from overseas (ST01-I) suggests some particular subtypes of L. monocytogenes lineage II might be more virulent to humans than others.
InlA is a key virulence factor that supports infection of epithelial cells by L. monocytogenes (38) . Nonsense mutations in inlA are reported to be at least partially responsible for an attenuated invasion phenotype (7, 24, (39) (40) (41) . These mutations may have accumulated as a result of selection for environmentally adapted ecotypes with reduced virulence, which do not require a fulllength InlA protein for ecological success (22) . Nightingale et al. (24) and Gray et al. (42) showed that inlA PMSCs were associated with about 40% of L. monocytogenes strains isolated from RTE foods in the United States. In France, 35% of food isolates, including seafood isolates, had a truncated InlA (43) . Felicio et al. (41) also reported similar rates from L. monocytogenes strains isolated from Alheira in Portugal. Controversially, Handa-Miya et al. (29) found inlA PMSCs in only 1.7% of L. monocytogenes strains isolated from RTE seafood in Japan. In accordance with the majority of these studies, 20% of L. monocytogenes strains from food and 67% of environment-related isolates in New Zealand have a PMSC in inlA. These strains might represent a low-risk group of L. monocytogenes strains.
L. monocytogenes isolates carrying inlA PMSCs have rarely been recovered from human listeriosis samples. A truncated InlA was not evident in any of the 61 L. monocytogenes isolates from abortion cases in France (43) . Furthermore, Van Stelten et al. (23) found that only 5.1% of human isolates have a PMSC in inlA, while two other studies in the United States provided further evidence that an inlA PMSC is uncommon in strains that cause listeriosis (22, 42) . Nightingale et al. (24) , however, revealed that 36.5% of the 52 human clinical isolates selected from ribotypes commonly associated with PMSCs carried an inlA PMSC, placing in doubt previous assumptions that a functional InlA protein is required for effective invasion. In our study, type 3 PMSC mutations were ubiquitous in ST03-N, which includes both environmental and clinical isolates, yet neither ST04-N from seafoodprocessing environments or clinical strains from New Zealand (ST01-N and ST17-N) had a PMSC. Furthermore, the invasiveness of ST03-N isolates was low compared with L. monocytogenes Scott A in a Caco-2 cell line assay, whereas ST01-N isolates had variable invasiveness. The reasons for the apparent underrepresentation of PMSCs in inlA in strains isolated from clinical samples and the mechanisms by which InlA-deficient strains cause disease remain to be determined. If InlA is important, but not essential, for invasion by L. monocytogenes, the low incidence of PMSCs detected may be related to the reduced virulence of clinical isolates carrying a truncated inlA gene.
Nightingale et al. (40) suggested that mutations in inlA are related to the genotype of L. monocytogenes (i.e., ribotype, ST, or pulsotype) rather than to the source of isolation (i.e., they are more likely to be due to founder effects and not causally linked to invasiveness). Orsi et al. (6) also suggest that infrequent reporting of the PMSCs in listeriosis-related strains may have resulted in the overrepresentation of 4b isolates in clinical samples in comparison to 1/2a strains (harboring inlA-PMSC), while the PMSC may have resulted in positive selection for strains with a truncated InlA protein during environmental adaptation. In general, 1/2a strains appear to be more likely to acquire genetic information by horizontal transfer or to undergo recombination events that may afford rapid adaptation to niche-specific stresses (44) . The increased mutability of these strains may have led to truncation of InlA as part of their niche adaptation.
Similar to our finding that isolates from human cases can harbor a PMSC, isolates with PMSCs have previously been associated with food-related outbreaks of listeriosis (e.g., the 1985 cheese outbreak in the United States and the 1988 pâté outbreak in the United Kingdom [40, 45] ). These outbreak strains showed attenuated invasion abilities when tested in Caco-2 cell lines, leading to the suggestion that their capacity to cause listeriosis may have been due to inlA-independent properties (e.g., better survival and growth in food and food-associated environments). Holch et al. (46) also showed that environmental L. monocytogenes strains harboring inlA-PMSC could cross the placental barrier in a similar way to a strain expressing a full-length inlA in pregnant mice and guinea pigs. These data suggest an inlA-independent pathway for invasion of certain tissues (e.g., the placenta and fetus). Given that ST03-N is apparently widespread in New Zealand, its ability to survive in food-associated environments may lead to sporadic cases, even though it is less virulent than other STs (e.g., ST04-N).
Eighteen PMSCs have previously been reported, but only one (PMSC type 3) was detected in L. monocytogenes from New Zealand. This PMSC was present in ST03-N, the most prevalent of our STs (Table 1) . Previous studies have shown that 11% of PMSCs in L. monocytogenes in RTE foods in the United States are PMSC type 3, while mutation type 1 accounts for 30% (24, 42) . Van Stelten et al. (23) also showed that PMSC mutation types 1, 3, and 4 represented Ͼ90% of the inlA mutations detected in 1,009 isolates, with PMSC type 3 the most common. These data indicate that L. monocytogenes isolates carrying PMSCs in inlA are distributed worldwide and that PMSC type 3 is relatively common among isolates (23, 40, 47) . PMSC type 3 is specifically associated with lineage II serotypes 1/2a and 1/2c (6, 8) .
Our results indicate that a PMSC mutation type 3 in inlA may produce an invasion capacity of strains in human cell lines lower than those of isolates that do not have such a PMSC. This might be expected to confer a significant attenuation of virulence on isolates carrying the PMSC. We also discovered, however, that two of the six L. monocytogenes isolates from clinical cases contained identical inlA PMSCs and were the likely causes of listeriosis. The isolation of identical STs in clinical and environmental isolates and the revelation that, in contrast to some other studies, a third of the isolates from cases of listeriosis carried a type 3 PMSC in inlA confirm that other factors are probably involved in the development of listeriosis. Careful assessment of possible pathogenicity markers other than inlA is required to ensure that the risk associated with environmentally persistent strains is fully understood.
In summary, our findings suggest New Zealanders are commonly exposed to virulence-attenuated L. monocytogenes strains. Although the risk associated with these strains is likely to be far lower than that of more invasive strains, some risk still exists that they may result in listeriosis. To gain a greater understanding of the risks associated with exposure to virulence-attenuated isolates, the genotypes of more isolates will need to be assessed. Their capacities to invade various cell lines will also need to be investigated more thoroughly.
